Go to Page # Page of 34
loading

CHB in Immunocompromised Patients & Real-World Study

 Wenhong Zhang
  14th-Jul-2019
Description: Here present CHB in immunocompromised patients and real-world study for long term outcome of antiviral treatment in chronic hepatitis B patients.
Views: 892
Domain: Medical
Category: Biotech/Pharma
Contributing Organization: VIROLOGY EDUCATION
 ‐ More of their Presentations
Contents:
CHB in immunocompromised patients and
Real world study for long term outcome of
antiviral treatment in chronic hepatitis B patients
Fudan University, Huashan Hospital
Department of Infectious Diseases

Wenhong Zhang
2019-05-25

Epidemiology and public health burden of chronic HBV infection

➢ Approximately 240 million people, or about 6 % of the world’s population, are chronically in ... See more

Recent Presentations

Yalin Firinci
19 August, 2019

Regulatory Science for R&D Promotion

At present, the nationís policy for Research and Development (R&D) promotion of innovative pharmaceuticals & improvement of environments for the R&D is formulated by Japanese gover

...
18 August, 2019
...
16 August, 2019